In a 56-year-old woman with a serum testosterone level of 48 ng/dL, is this value normal and does it require treatment?

Testosterone Level of 48 ng/dL in a 56-Year-Old Woman

A testosterone level of 48 ng/dL in a 56-year-old postmenopausal woman falls within the expected range for this age group and does not require treatment unless she has specific symptoms of hypogonadal sexual desire disorder (HSDD) that significantly impair quality of life.

Understanding the Context

Your patient's testosterone level needs to be interpreted carefully based on several critical factors:

Normal Reference Ranges for Women

The evidence shows significant variability in what constitutes "normal" testosterone in women, with important caveats:

• Premenopausal women (ages 18-49): Reference ranges show 5th-95th percentiles of approximately 15-46 ng/dL for total testosterone 1
• Postmenopausal women: Recent population data from NHANES shows a weighted mean of 25.2 ng/dL, with 79.9% of postmenopausal women having levels <30 ng/dL 2
• Age-related decline: Androgen levels decline by approximately 50% from the early 20s to mid-40s, continuing into menopause 3

Your patient's level of 48 ng/dL is actually above the median for postmenopausal women and falls within normal physiologic ranges.

Critical Laboratory Considerations

The guidelines emphasize a major problem with testosterone testing in women 4:

• Many commercial laboratories provide inaccurate normal ranges that are far too high for women
• Commercial lab "normal" ranges often extend to 95 ng/dL, making detection of true hyperandrogenemia nearly impossible 5
• Testosterone assays designed for men lack sensitivity and accuracy in the female range 6
• You must use a specialty laboratory with validated assays for women to interpret results accurately

When to Consider Treatment

The ONLY Evidence-Based Indication

Testosterone therapy in women is indicated ONLY for hypogonadal sexual desire disorder (HSDD) in postmenopausal women 7. This requires:

1. Persistent, distressing low sexual desire that causes personal distress
2. No other identifiable causes (relationship issues, medications, depression, other medical conditions)
3. Adequate estrogen status (if applicable)
4. Full clinical assessment before initiating therapy

What NOT to Do

• Do NOT use testosterone levels to diagnose HSDD - the diagnosis is clinical, not laboratory-based 7
• Do NOT treat based on a number alone - there is no validated testosterone deficiency threshold for women
• Do NOT use testosterone for bone health, cognitive function, general well-being, or disease prevention - insufficient evidence 7

Clinical Algorithm for Your Patient

Step 1: Assess for Hyperandrogenism (Not Deficiency)

At 48 ng/dL, you should actually be considering whether this represents hyperandrogenism, not deficiency:

Look for clinical signs:

• Hirsutism (Ferriman-Gallwey score)
• Acne or seborrhea
• Male-pattern baldness
• Menstrual irregularities (if perimenopausal)
• Virilization signs

If present, evaluate for:

• Polycystic ovary syndrome (PCOS) - most common cause 4, 6
• Adrenal hyperandrogenism
• Ovarian or adrenal tumors (if testosterone >200 ng/dL or DHEAS >600 µg/dL) 8

Step 2: If No Hyperandrogenic Signs

Assess for HSDD symptoms:

• Persistent lack of sexual desire causing personal distress
• Duration and severity of symptoms
• Impact on quality of life and relationships

Rule out other causes:

• Medications (SSRIs, antihypertensives, oral contraceptives, oral estrogens)
• Depression or anxiety
• Relationship problems
• Inadequate estrogen status
• Other medical conditions (hypothyroidism, hyperprolactinemia)

Step 3: Management Decision

If HSDD is present and other causes excluded:

• Consider testosterone therapy trial
• Use formulations achieving physiological premenopausal concentrations
• Monitor testosterone levels regularly (target: premenopausal range, approximately 15-46 ng/dL total testosterone)
• No FDA-approved female formulations exist; male formulations can be used judiciously at lower doses
• Avoid compounded testosterone 7

If no HSDD or other symptoms:

• No treatment indicated
• Reassure patient this is a normal level for her age
• Address any other health concerns separately

Important Caveats

Safety Considerations

• Long-term safety of testosterone therapy in women has not been established 7
• Women at high cardiometabolic risk were excluded from most studies
• Monitor for virilization signs (voice deepening, clitoromegaly, increased facial hair)
• Regular monitoring of lipids and metabolic parameters recommended

Common Pitfalls to Avoid

1. Using commercial lab reference ranges - they are often inaccurate for women 4, 5
2. Treating a number instead of symptoms - testosterone levels do not correlate well with symptoms in women
3. Assuming age-related decline requires treatment - physiologic decline is normal and not an indication for therapy
4. Using testosterone for non-sexual complaints - no evidence supports this

Bottom Line for This Patient

With a testosterone level of 48 ng/dL and no mention of HSDD symptoms, this 56-year-old woman does not require testosterone therapy. Her level is physiologically normal for a postmenopausal woman. Focus your clinical assessment on whether she has distressing sexual symptoms that meet criteria for HSDD and cannot be explained by other factors. Only then would testosterone therapy be evidence-based and appropriate.